Association of non-invasive markers of liver fibrosis with HCV coinfection and antiretroviral therapy in patients with HIV
No Thumbnail Available
Date
2019-08-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The aim of this study was to assess the main effects and interaction between viral hepatitis C (HCV) coinfection and antiretroviral therapy (ART) by using a nonparametric ANOVA on direct and indirect markers of liver fibrosis in HIV-infected patients. The sample included 178 HIV patients aged from 23 to 65 (36% females). The following parameters were determined in blood of patients: hyaluronic acid, pro-matrix metalloproteinase-1, alanine aminotransferase, aspartate aminotransferase, and platelet count. The FIB-4 index was also calculated. The nonparametric ANOVA revealed no significant interaction between HCV coinfection and ART. This provides evidence for an independent contribution of each factor on promotion of the pathology. The results also demonstrated that the direct and indirect indicators of liver fibrosis are associated differently with the studied factors. Therefore, a combination of markers should be used for monitoring of liver fibrosis in HIV-infected patients.
Description
Publisher Copyright: © 2019 Oksana Koļesova et al., published by Sciendo 2019. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.
Keywords
ALT, AST, FIB-4, hyaluronic acid, liver fibrosis, nonparametric ANOVA, pro-MMP-1, 3.2 Clinical medicine, 3.3 Health sciences, 1.1. Scientific article indexed in Web of Science and/or Scopus database, General, SDG 3 - Good Health and Well-being
Citation
Koļesova, O, Eglite, J, Koļesovs, A, Krumiņa, A, Ekšteina, I, Madelane, M & Viksna, L 2019, 'Association of non-invasive markers of liver fibrosis with HCV coinfection and antiretroviral therapy in patients with HIV', Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences, vol. 73, no. 4, pp. 400-402. https://doi.org/10.2478/prolas-2019-0062